Apellis Pharmaceuticals, Inc.APLSNASDAQ
Loading
Net Margin Over TimeExpanding
Percentile Rank100
Studio
Year-over-Year Change

Net income as a percentage of revenue

Latest
2.23%
↑ 101% vs avg
Percentile
P100
Near historical high
Streak
4 yr
Consecutive growthExpanding
Average
-325.71%
Historical baseline
PeriodValueYoY Change
TTM2.23%+108.8%
2024-25.32%+81.0%
2023-133.29%+84.6%
2022-864.70%+22.9%
2021-1121.27%-714.9%
2020-137.59%-
20190.00%-